Does rosuvastatin offer therapeutic potential in autoimmune thyroiditis in nonobese diabetic mice?

Clinical Immunology

Volumn 130, Issue 3, 2009, Pages 375-377

  Mori, Kouki ^a   Yoshida, Katsumi ^a   Nakagawa, Yoshinori ^a   Hoshikawa, Saeko ^a   Ozaki, Hiroshi ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONCANAVALIN A; GAMMA INTERFERON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; IODIDE; ROSUVASTATIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; AUTOIMMUNE THYROIDITIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; HASHIMOTO DISEASE; LETTER; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICE; MICE, INBRED NOD; PYRIMIDINES; SODIUM IODIDE; SPLEEN; SULFONAMIDES; THYROGLOBULIN; THYROIDITIS, AUTOIMMUNE;

EID: 59249090109     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.10.002     Document Type: Letter

References (13)

1. McCarey D.W., Sattar N., and McInnes I.B. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?. Arthritis Res. Ther. 7 (2005) 55-61
2. Youssef S., Stüve O., Patarroyo J.C., Ruiz P.J., Radosevich J.L., Hur E.M., Bravo M., Mitchell D.J., Sobel R.A., Steinman L., and Zamvil S.S. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
3. Leung B.P., Sattar N., Crilly A., Prach M., McCarey D.W., Payne H., Madhok R., Campbell C., Gracie J.A., Liew F.Y., and McInnes I.B. A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J. Immunol. 170 (2003) 1524-1530
4. Champion B.R., Cooke A., and Rayner D.C. Thyroid autoimmunity. Curr. Opin. Immunol. 4 (1992) 770-778
5. Tani J.-I., Mori K., Hoshikawa S., Nakazawa T., Satoh J., Nakagawa Y., Ito S., and Yoshida K. Prevention of lymphocytic thyroiditis in iodide-treated non-obese diabetic mice lacking interferon regulatory factor-1. Eur. J. Endocrinol. 147 (2002) 809-814
6. Jin Z., Mori K., Fujimori K., Hoshikawa S., Tani J.-I., Satoh J., Ito S., Satomi S., and Yoshida K. Experimental autoimmune thyroiditis in non-obese diabetic mice lacking interferon regulatory factor-1. Clin. Immunol. 113 (2004) 187-192
7. Gegg M.E., Harry R., Hankey D., Zambarakji H., Pryce G., Baker D., Adamson P., Calder V., and Greenwood J. Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction. J. Immunol. 174 (2005) 2327-2335
8. Palmer G., Chobaz V., Talabot-Ayer D., Taylor S., So A., Gabay C., and Busso N. Assessment of the efficacy of different statins in murine collagen-induced arthritis. Arthritis Rheum. 50 (2004) 4051-4059
9. McKay A., Leung B.P., McInnes I.B., Thompson N.C., and Liew F.Y. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J. Immunol. 172 (2004) 2903-2908
10. McTaggart F., Buckett L., Davidson R., Holdgate G., McCormick A., Schneck D., Smith G., and Warwick M. Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am. J. Cardiol 87 Suppl (2001) 28B-32B
11. Monetti M., Canavesi M., Camera M., Parente R., Paoletti R., Tremoli E., Corsini A., and Bellosta S. Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice. Pharmacol. Res. 55 (2007) 441-449
12. Duntas L.H. Thyroid disease and lipids. Thyroid 12 (2002) 287-293
13. Gullu S., Emral R., Bastemir M., Parkes A.B., and Lazarus J.H. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis. Eur. J. Endocrinol. 153 (2005) 41-48